The future of the life sciences industry hinges on AI and automation, driving innovation in drug discovery and addressing ...

John Arena is interim president of global pharma services at Cencora, managing a team that offers a broad range of solutions ...

Bajaj Broking Research recommends Piramal Pharma and PTC India for the upcoming week. Nifty is expected to remain volati ...

2025 is finally upon us and the trends for healthcare marketers continue to evolve.

Jyotivardhan Jaipuria, Founder & MD, Valentis Advisors, is more optimistic about the market after the correction. He believes ...

Short answer: most likely, yes. Clearly, navigating emerging markets will require a great deal of time and effort by pharma. These markets are highly dynamic, and the regional variations in ...

Mallinckrodt Pharmaceuticals and Endo have agreed to combine in a nearly $7bn deal after the pair emerged from bankruptcy processes linked to liabilities over the US opioid crisis.

In addition to a continued focus on growing drug pipelines, and the increasing use of artificial intelligence (AI) and data ...

Asserting that quality standards are not region-dependent, the Indian Pharmaceutical Alliance (IPA) on Wednesday refuted the ...

Traditional approaches to benchmarking brand performance have struggled to keep pace with industry dynamics. While individual ...

Chromatography companies recognize significant opportunities in the biotech and pharma sectors, yet face uncertainty driven by rising tariffs and the growing integration of AI tools.

Balaxi Pharma is a pharmaceutical company centered on branded intellectual property rights, targeting emerging markets and boasting an extensive and expanding range of medications across various ...